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ROLE OF SYMPTOMS DURATION AS PROGNOSTICATOR FOR SACRAL 
NEUROMODULATION IN REFRACTORY OVERACTIVE BLADDER 
 
Hypothesis / aims of study 
Sacral neuromodulation (SNM) offers a well-tolerated treatment option for patients with overactive bladder syndrome (OAB) 
refractory to conservative treatment. The advantageous effect of SNM depends on the accurate identification of suitable 
candidates during pre-implant percutaneous nerve evaluation. In the Literature there are conflicting data regarding the role of 
age, duration of complaints and neurogenic bladder dysfunction in predicting the effect of SNM, and  up to-date no specific 
urological pre-treatment factors have been associated with response to SNM. The aim of this multicentric study was to 
investigate data from 103 patients with refractoy OAB who underwent SNM implant in order to evaluate the role of symptoms 
duration as possible pre-treatment prognosticator.  
 
Study design, materials and methods 
From September 2001 to November 2010 a total of 103 patients attending four different urological centres with refractory OAB 
underwent a temporary SNM implant.  
Patient data (demographics, medical history,urologic investigations, and diagnosis) were collected. Temporary implant results 
were evaluated from a voiding diary and patient history. More than 50% improvement of voiding parameters was considered a 
successful SNM and those patients were selected for implantation. We test the duration of complaints as prognosticator for 
predicting SNM result. We performed the Pearson correlation analysis. For comparison between groups either Student's t test 
or Mann-Whitney test were used, as appropriate.  
 
 
 
 
 
Results 
Eighty patients (77%) underwent a definitive implant. At a mean follow-up of 25.2  22.9 months we observed a significant 
decrease (p<0.001) in the mean number of incontinence episodes/die (1.3± 1.9 versus 4.6±2.4), number of pads/die (1.2 ± 1.4 
versus 3.7 ± 2.2), daily urinary frequency (8.7 ± 2.8 micturitions/die versus 12.7 ± 4.8). Stratifying patients according to the 
lower urinary tract dysfunction aetiology (idiopathic, neurogenic, iatrogenic), we did not find any significant correlation between 
symptoms duration (neither as continuous nor categorical variables) and the improvement rates of incontinence episodes 
(figures 1-2), and micturition frequency (figures 3-4), although we observed better results mainly in neurogenic patients with < 4-
year history of urinary symptoms (figure 5).  
 
Interpretation of results 
Patients with urgency and urge urinary incontinence due to neurogenic lower urinary tract dysfunction for a relatively long period 
of time may have a lower chance of a positive test compared with patients with neurogenic dysfunction for a relatively short 
period.  
 
Concluding message 
Duration of complaints was not found to be significant predictive factor for the success of SNM.  
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